NO964760L - MSRV-1 virus and pathogenic and / or infectious MSRV-2 agent associated with rheumatoid arthritis - Google Patents
MSRV-1 virus and pathogenic and / or infectious MSRV-2 agent associated with rheumatoid arthritisInfo
- Publication number
- NO964760L NO964760L NO964760A NO964760A NO964760L NO 964760 L NO964760 L NO 964760L NO 964760 A NO964760 A NO 964760A NO 964760 A NO964760 A NO 964760A NO 964760 L NO964760 L NO 964760L
- Authority
- NO
- Norway
- Prior art keywords
- msrv
- pathogenic
- virus
- rheumatoid arthritis
- strains
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Abstract
Oppfinnelsen gjelder anvendelse av et viralt materiale i renset eller iso- lert tilstand, med reverstranskriptase- aktivitet, beslektet med en familie av endogene, retrovirale elementer, og/eller av et patogent og/eller infek- siøst middel i renset eller isolert tilstand som er forskjellig fra det ovenfor nevnte virale materialet, hvor begge er avledet fra en virusstamme med reverstranskriptaseaktivitet valgt blant stammene betegnet POL-2, deponert 22.07.92 hos ECACC under aksesjons- betegnelsen V92072202, henholdsvis MS7- PG, deponert 08.01.93 hos ECACC under aksesjonsbetegnelsen V93010816, og fra variantstammene av disse, som består av virus som omfatter minst ett antigen som gjenkjennes av minst ett antistoff rettet mot minst ett antigen som til- svarer ethvert av virusene fra de oven- for nevnte virusstammer POL-2 og MS7PG, for å fremstille et diagnostisk, profy- laktisk eller terapeutisk preparat for påvisning, forebyggelse eller behand- ling av en infeksjon av dette virale materialet og/eller patogene og/eller infeksiøse middel, forbundet med reumatoid artritt.The invention relates to the use of a viral material in the purified or isolated state, with reverse transcriptase activity, related to a family of endogenous, retroviral elements, and / or of a pathogenic and / or infectious agent in the purified or isolated state which is different from the aforementioned viral material, both of which are derived from a virus strain with reverse transcriptase activity selected from the strains designated POL-2, deposited 22.07.92 with ECACC under accession designation V92072202, respectively MS7-PG, deposited 08.01.93 with ECACC under accession sign V93010816, and from its variant strains, consisting of viruses comprising at least one antigen recognized by at least one antibody directed to at least one antigen corresponding to any of the viruses of the aforementioned virus strains POL-2 and MS7PG, to prepare a diagnostic, prophylactic or therapeutic preparation for the detection, prevention or treatment of an infection of this viral ma the terial and / or pathogenic and / or infectious agent associated with rheumatoid arthritis.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9502960A FR2731356B1 (en) | 1995-03-09 | 1995-03-09 | MSRV-1 VIRUS AND PATHOGENIC AND / OR INFECTING MSRV-2 AGENT ASSOCIATED WITH RHUMATOID POLYARTHRITIS |
PCT/FR1996/000360 WO1996028552A1 (en) | 1995-03-09 | 1996-03-07 | Rheumatoid arthritis-related virus msrv-1 and pathogenic and/or infective agent msrv-2 |
Publications (2)
Publication Number | Publication Date |
---|---|
NO964760L true NO964760L (en) | 1996-11-08 |
NO964760D0 NO964760D0 (en) | 1996-11-08 |
Family
ID=9477022
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO964760A NO964760D0 (en) | 1995-03-09 | 1996-11-08 | MSRV-1 virus and pathogenic and / or infectious MSRV-2 agent associated with rheumatoid arthritis |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP0731168A1 (en) |
JP (1) | JPH08322579A (en) |
AU (1) | AU5007396A (en) |
BR (1) | BR9605926A (en) |
CA (1) | CA2171242A1 (en) |
CZ (1) | CZ328796A3 (en) |
FR (1) | FR2731356B1 (en) |
NO (1) | NO964760D0 (en) |
NZ (1) | NZ303694A (en) |
PL (1) | PL317200A1 (en) |
WO (1) | WO1996028552A1 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2737500B1 (en) * | 1995-08-03 | 1997-08-29 | Bio Merieux | VIRAL MATERIAL AND NUCLEOTIDE FRAGMENTS ASSOCIATED WITH MULTIPLE SCLEROSIS, FOR DIAGNOSIS, PROPHYLACTICS AND THERAPEUTICS |
US6582703B2 (en) * | 1996-11-26 | 2003-06-24 | Bio Merieux | Isolated nucleotide sequences associated with multiple sclerosis or rheumatoid arthritis and a process of detecting |
DE69836484T2 (en) * | 1997-07-07 | 2007-09-13 | Bio Merieux | Endogenous retroviral genomic cliniin element associated with autoimmune disease and / or perturbation, use as a marker |
FR2765588A1 (en) | 1997-07-07 | 1999-01-08 | Bio Merieux | RETROVIRAL NUCLEIC MATERIAL AND NUCLEOTIDE FRAGMENTS ESPECIALLY ASSOCIATED WITH MULTIPLE SCLEROSIS AND / OR RHUMATOID POLYARTHRITIS, FOR DIAGNOSIS, PROPHYLACTICS AND THERAPEUTICS |
FR2788784A1 (en) * | 1999-01-21 | 2000-07-28 | Bio Merieux | New nucleic acid from human endogenous retrovirus, useful e.g. for diagnosis of autoimmune disease and complications of pregnancy, contains at least part of the gag gene |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2689520B1 (en) * | 1992-04-03 | 1996-07-19 | Bio Merieux | METHOD AND CULTURE MEDIUM FOR OBTAINING CELLS INFECTED WITH A VIRUS ASSOCIATED WITH MULTIPLE SCLEROSIS. |
GB9310657D0 (en) * | 1993-05-24 | 1993-07-07 | Univ London | Retrovirus |
ES2233936T3 (en) * | 1994-02-04 | 2005-06-16 | Bio Merieux | VIRUS MSRV1 ASSOCIATED WITH SCLEROSIS IN PLATES, ITS NUCLEIC CONSTITUENTS AND ITS APPLICATIONS. |
-
1995
- 1995-03-09 FR FR9502960A patent/FR2731356B1/en not_active Expired - Fee Related
-
1996
- 1996-03-05 EP EP96420070A patent/EP0731168A1/en not_active Withdrawn
- 1996-03-07 CA CA002171242A patent/CA2171242A1/en not_active Abandoned
- 1996-03-07 BR BR9605926A patent/BR9605926A/en not_active Application Discontinuation
- 1996-03-07 WO PCT/FR1996/000360 patent/WO1996028552A1/en not_active Application Discontinuation
- 1996-03-07 PL PL96317200A patent/PL317200A1/en unknown
- 1996-03-07 NZ NZ303694A patent/NZ303694A/en unknown
- 1996-03-07 AU AU50073/96A patent/AU5007396A/en not_active Abandoned
- 1996-03-07 CZ CZ963287A patent/CZ328796A3/en unknown
- 1996-03-08 JP JP8091642A patent/JPH08322579A/en not_active Withdrawn
- 1996-11-08 NO NO964760A patent/NO964760D0/en unknown
Also Published As
Publication number | Publication date |
---|---|
EP0731168A1 (en) | 1996-09-11 |
NZ303694A (en) | 1997-11-24 |
FR2731356A1 (en) | 1996-09-13 |
BR9605926A (en) | 1997-09-02 |
CA2171242A1 (en) | 1996-09-10 |
WO1996028552A1 (en) | 1996-09-19 |
FR2731356B1 (en) | 1997-04-30 |
AU5007396A (en) | 1996-10-02 |
JPH08322579A (en) | 1996-12-10 |
CZ328796A3 (en) | 1997-03-12 |
NO964760D0 (en) | 1996-11-08 |
PL317200A1 (en) | 1997-03-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BHAT et al. | The galactosyl ceramide/sulfatide receptor binding region of HIV-1 gp120 maps to amino acids 206-275 | |
NO953925D0 (en) | MSRV1 virus and MSRV2 pathogenic and / or infectious agent associated with multiple sclerosis, nucleic acid components and their use | |
CA2073031A1 (en) | Anti-cd4 antibody homologs useful in prophylaxis and treatment of aids, arc and hiv infection | |
DK33190A (en) | HIV-3 RETROVIRUS AND ITS USE | |
KR950032278A (en) | Peptides Derived from Retroviruses of the Human Immunodeficiency Virus Group and Uses thereof | |
US5550052A (en) | Hybrid cell line formed between T4 lymphocytes and tumoral lymphoid type cells | |
WO1996012809A3 (en) | Nucleotide sequences of hiv-1 type (or subtype) o retrovirus antigens | |
DE3855134T2 (en) | MONOCLONAL HUMAN ANTIBODIES AGAINST HIV-I | |
ATE309365T1 (en) | GROUP 0 HIV-1, CORRESPONDING FRAGMENTS OF THIS VIRUS AND THEIR APPLICATIONS | |
Cotropia et al. | A human monoclonal antibody to HIV-1 gp41 with neutralizing activity against diverse laboratory isolates | |
DK0494294T3 (en) | Bacterial stress proteins | |
NO964760L (en) | MSRV-1 virus and pathogenic and / or infectious MSRV-2 agent associated with rheumatoid arthritis | |
AU8010791A (en) | Hiv monoclonal antibody | |
ATE435034T1 (en) | EXPRESSION AND CHARACTERIZATION OF AN HIV-1 ENVELOPE PROTEIN ASSOCIATED WITH A BROADLY REACTIVE NEUTRALIZING ANTIBODY RESPONSE. | |
Pal et al. | Conformational perturbation of the envelope glycoprotein gp120 of human immunodeficiency virus type 1 by soluble CD4 and the lectin succinyl Con A | |
McPhee et al. | Anomalies in Nef expression within the central nervous system of HIV-1 positive individuals/AIDS patients with or without AIDS dementia complex | |
Gerenčer et al. | The role of complement and gp120-specific antibodies in virus lysis and CD4+ T cell depletion in HIV-1-infected patients | |
CA2109961A1 (en) | Peptides for use in induction of t cell activation against hiv-1 | |
SU1768637A1 (en) | Strain of human immunodeficient virus 1-type for preparation of diagnostic preparation | |
EP0250128A3 (en) | Novel virus isolated from patients with aids | |
Bose et al. | Seroepidemiological investigations on human immunodeficiency virus infections in some parts of India | |
Zhang et al. | Human T Lymphotropic Virus Types 1-and II-Specific Antibody-Dependent Cellular Cytotoxicity: Strain Specificity and Epitope Mapping | |
EP0400245B1 (en) | Proteins and glycoproteins of the HIV-2 EHO retrovirus antibodies directed against them - application for the diagnosis | |
US20010007017A1 (en) | Peptides which react with antibody representing the prognostic marker for hiv disease progression | |
Hioe et al. | Resting cell neutralization assay for HIV-1 primary isolates |